Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies.

ABSTRACT:

SUBMITTER: Dragoni F 

PROVIDER: S-EPMC8923034 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature